LEQSELVI Film-coated tablet Ref.[116129] Active ingredients: Deuruxolitinib

Source: FDA, National Drug Code (US)  Revision Year: 2025 

Product description

LEQSELVI (deuruxolitinib) tablets contain the phosphate salt of deuruxolitinib, a Janus kinase (JAK) inhibitor, for oral administration.

Deuruxolitinib phosphate is a white to off-white crystalline solid with the chemical name 1HPyrazole-1-propanenitrile, β-(cyclopentyl-2,2,3,3,4,4,5,5d8)-4-(7Hpyrrolo[2,3d]pyrimidin-4-yl)-, (βR)-, phosphate (1:1).

Deuruxolitinib has high aqueous solubility at low pH. Deuruxolitinib phosphate has a molecular weight of 412.42 g/mol and a molecular formula of C17H13D8N6O4P. The structural formula is:

Each tablet contains 8 mg of deuruxolitinib (equivalent to 10.50 mg of deuruxolitinib phosphate) and the following excipients: colloidal silicon dioxide, lactose monohydrate, low-substituted hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose and povidone. The tablet film coating contains the following excipients: carmine, FD&C blue #2 aluminum lake, glyceryl mono and dicaprylocaprate, polyvinyl alcohol, sodium lauryl sulfate, talc, and titanium dioxide.

Dosage Forms and Strengths

Tablet: purple, round, debossed with "C" on one side and "8" on the other side.

How Supplied

LEQSELVI tablets are packaged in white, high-density polyethylene (HDPE) bottles and closed with 24 mm white child-resistant caps with foil liner. Each bottle contains 1 g silica-gel canister. LEQSELVI is available as purple, round, immediate-release tablets debossed with "C" on one side and "8" on the other side:

  • 8 mg: 60 tablets in a bottle; NDC: 47335-108-86

Manufactured for Sun Pharmaceutical Industries, Inc by: Halo Pharmaceutical, Inc, Whippany, NJ, 07981, USA

Drugs

Drug Countries
LEQSELVI United Kingdom, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.